A toxicologist by training, Dr. Vandivort’s graduate/postdoctoral work as an NIH Training Grant recipient at the University of Washington and Cedars-Sinai Medical Center focused on the role of extracellular matrix proteins in the acute and chronic immune response to sterile and non-sterile injury. During his more than 5 years of contract research organization (CRO) experience, first as an Immunotoxicology Research Scientist at Charles River Laboratories, and then as a consultant in the Regulatory Affairs and Scientific & Strategic Development group at Medpace, Tyler has cultivated an understanding of the key procedural and strategic components of nonclinical and early phase clinical development that drive program success. He received a Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professionals Society (RAPS) in 2019.